Adjuvant therapy for surgically resected pancreatic adenocarcinoma.
Publication
, Journal Article
Abbruzzese, JL
Published in: JAMA
March 5, 2008
Duke Scholars
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
March 5, 2008
Volume
299
Issue
9
Start / End Page
1066 / 1067
Location
United States
Related Subject Headings
- Pancreatic Neoplasms
- Humans
- General & Internal Medicine
- Gemcitabine
- Fluorouracil
- Deoxycytidine
- Chemotherapy, Adjuvant
- Antimetabolites, Antineoplastic
- Adenocarcinoma
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Abbruzzese, J. L. (2008). Adjuvant therapy for surgically resected pancreatic adenocarcinoma. JAMA, 299(9), 1066–1067. https://doi.org/10.1001/jama.299.9.1066
Abbruzzese, James L. “Adjuvant therapy for surgically resected pancreatic adenocarcinoma.” JAMA 299, no. 9 (March 5, 2008): 1066–67. https://doi.org/10.1001/jama.299.9.1066.
Abbruzzese JL. Adjuvant therapy for surgically resected pancreatic adenocarcinoma. JAMA. 2008 Mar 5;299(9):1066–7.
Abbruzzese, James L. “Adjuvant therapy for surgically resected pancreatic adenocarcinoma.” JAMA, vol. 299, no. 9, Mar. 2008, pp. 1066–67. Pubmed, doi:10.1001/jama.299.9.1066.
Abbruzzese JL. Adjuvant therapy for surgically resected pancreatic adenocarcinoma. JAMA. 2008 Mar 5;299(9):1066–1067.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
March 5, 2008
Volume
299
Issue
9
Start / End Page
1066 / 1067
Location
United States
Related Subject Headings
- Pancreatic Neoplasms
- Humans
- General & Internal Medicine
- Gemcitabine
- Fluorouracil
- Deoxycytidine
- Chemotherapy, Adjuvant
- Antimetabolites, Antineoplastic
- Adenocarcinoma
- 42 Health sciences